Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
This has been a bad decision for me to come here. I had a very stable great paying job. This company is a rollercoaster.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
My coworkers are really smart and insightful
Was sind einige der besten Dinge an Ihrem Team?
We all know we are in it together
Warum fühlen Sie sich unterbewertet und was würde Sie bei Ihrer Vergütung besser fühlen lassen?
The bonus plan for HOS’s is terrible. Even high volume
Was läuft falsch und wie kann es verbessert werden?
Manager micromanaging. Texts and calls after hours. Treats us like we are idiots.
Was braucht das Führungsteam, um besser zu werden?
Understanding the limits of marketability of xpovio in a crowed space with really good other options. Covid and the fact that the market doesn?
Other Employee Reviews for Karyopharm Therapeutics
×